Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleSpecial Contributions

Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials

Michael M. Graham, Richard L. Wahl, John M. Hoffman, Jeffrey T. Yap, John J. Sunderland, Ronald Boellaard, Eric S. Perlman, Paul E. Kinahan, Paul E. Christian, Otto S. Hoekstra and Gary S. Dorfman
Journal of Nuclear Medicine June 2015, 56 (6) 955-961; DOI: https://doi.org/10.2967/jnumed.115.158402
Michael M. Graham
1Division of Nuclear Medicine, Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
2Department of Radiology, Washington University School of Medicine, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John M. Hoffman
3Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey T. Yap
3Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John J. Sunderland
1Division of Nuclear Medicine, Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Boellaard
4Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric S. Perlman
5Perlman Advisory Group, LLC, Hillsdale, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul E. Kinahan
6Department of Radiology, University of Washington, Seattle, Washington; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul E. Christian
3Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto S. Hoekstra
4Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary S. Dorfman
7Department of Radiology, Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 56 (6)
Journal of Nuclear Medicine
Vol. 56, Issue 6
June 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
Michael M. Graham, Richard L. Wahl, John M. Hoffman, Jeffrey T. Yap, John J. Sunderland, Ronald Boellaard, Eric S. Perlman, Paul E. Kinahan, Paul E. Christian, Otto S. Hoekstra, Gary S. Dorfman
Journal of Nuclear Medicine Jun 2015, 56 (6) 955-961; DOI: 10.2967/jnumed.115.158402

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
Michael M. Graham, Richard L. Wahl, John M. Hoffman, Jeffrey T. Yap, John J. Sunderland, Ronald Boellaard, Eric S. Perlman, Paul E. Kinahan, Paul E. Christian, Otto S. Hoekstra, Gary S. Dorfman
Journal of Nuclear Medicine Jun 2015, 56 (6) 955-961; DOI: 10.2967/jnumed.115.158402
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CONTEXT OF THE IMAGING PROTOCOL WITHIN THE CLINICAL TRIAL
    • SITE SELECTION, QUALIFICATION, AND TRAINING
    • SUBJECT SCHEDULING
    • SUBJECT PREPARATION
    • IMAGING-RELATED SUBSTANCE PREPARATION AND ADMINISTRATION
    • IMAGING PROCEDURE
    • IMAGE POSTPROCESSING
    • IMAGE ANALYSIS
    • IMAGE INTERPRETATION
    • ARCHIVING AND DISTRIBUTION OF DATA
    • Quality Control (QC)
    • IMAGING-ASSOCIATED RISKS AND RISK MANAGEMENT
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Advantages and Challenges of Total-Body PET/CT at a Tertiary Cancer Center: Insights from Sun Yat-sen University Cancer Center
  • Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
  • Brown Adipose Tissue: A Protective Mechanism Against "Preprediabetes"?
  • Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
  • Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
  • Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma
  • Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials
  • Does PET SUV Harmonization Affect PERCIST Response Classification?
  • Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation
  • Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size
  • Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
  • The Value of Establishing the Quantitative Accuracy of PET/CT Imaging
  • Google Scholar

More in this TOC Section

  • The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents
  • Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites
  • American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET
Show more Special Contributions

Similar Articles

Keywords

  • fluorodeoxyglucose
  • PET CT
  • Protocol
  • Guideline
SNMMI

© 2025 SNMMI

Powered by HighWire